D,L-Threo-3-Hydroxyaspartic Acid

D,L-Threo-3-Hydroxyaspartic Acid

SCHEMBL5513561

NC(=O)C(O)[C@H](N)C(=O)O.N[C@H](C(=O)O)C(O)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
SLC7A5 Q01650 1/20 0.42
USP2 O75604 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
ACHE P22303 2/20 0.32
BLM P54132 2/20 0.31
NR1I2 O75469 1/20 0.31
PTGS1 P23219 1/20 0.31
ADRA1A P35348 1/20 0.31
LMNA P02545 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALOX15 P16050 1/20 0.31
PMP22 Q01453 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2C9 P11712 1/20 0.31
PDE4A P27815 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31000531 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
SCHEMBL1867460 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
SCHEMBL1867465 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
SCHEMBL2367281 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
SCHEMBL1867463 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
SCHEMBL23924442 0.95 SLC7A5 (0.46) TSHRSLC7A5USP2SLCO1B1SLC1A3
D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL2553076 0.89 TSHR (0.56) TSHRSLC7A5USP2SLCO1B1SLC1A3
D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL5019049 0.89 TSHR (0.56) TSHRSLC7A5USP2SLCO1B1SLC1A3
D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL336361 0.89 TSHR (0.56) TSHRSLC7A5USP2SLCO1B1SLC1A3
D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL336363 0.89 TSHR (0.56) TSHRSLC7A5USP2SLCO1B1SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814588-A2 ANTIINFECTIVE LIPOPEPTIDES Cubist Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2006110185-A2 ANTIINFECTIVE LIPOPEPTIDES CUBIST PHARMACEUTICALS, INC. (US) 2006-10-19 WO disclosed